FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Bosl

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Retroperitoneal Space

Co-author Network

Publications

TOP 3
Hege S Haugnes; Jan Oldenburg; Jourik A Gietema; Hink Boer; George J Bosl; Roy M Bremnes; Marianne Brydøy; Alv A Dahl; Sophie D Fosså
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Timothy A Masterson; Joseph A Pettus; E Jason Abel; George J Bosl; Brett S Carver; Joel Sheinfeld
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour.
Timothy A Masterson; Robert J Motzer; Bobby Shayegan; George J Bosl; Brett S Carver; Darren R Feldman; Joel Sheinfeld
Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Bosl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Hege S Haugnes; Jan Oldenburg; Jourik A Gietema; Hink Boer; George J Bosl; Roy M Bremnes; Marianne Brydøy; Alv A Dahl; Sophie D Fosså
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(30):3752-63.
2012: Timothy A Masterson; Joseph A Pettus; E Jason Abel; George J Bosl; Brett S Carver; Joel Sheinfeld
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour.
BJU international 2012;110(7):950-5.
2012: Timothy A Masterson; Robert J Motzer; Bobby Shayegan; George J Bosl; Brett S Carver; Darren R Feldman; Joel Sheinfeld
Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.
Urology 2012;79(5):1079-84.
2012: Darren R Feldman; Michelle S Ginsberg; Dean F Bajorin; George J Bosl; Maryann Carousso; Sujata Patil; Joel Sheinfeld; Michael J Trinos; Robert J Motzer
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.
Cancer 2012;118(4):981-6.
2012: R Houston Thompson; Dean Bajorin; George J Bosl; Brett S Carver; Darren Feldman; Robert Motzer; Victor E Reuter; Joel Sheinfeld
Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection.
Urology 2012;79(2):361-4.
2012: Francesca Cavallo; Raju S K Chaganti; Darren R Feldman; Grazia Graziani; Jane Houldsworth; Maria Jasin; Mary Ellen Moynahan; Cristina Antinozzi; George J Bosl; marco barchi
Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
PloS one 2012;7(12):e51563.
2011: Inderpal S Sarkaria; Camelia S Sima; Shelly Sood; Manjit S Bains; George J Bosl; Raja M Flores; Robert J Motzer; Victor E Reuter; Valerie W Rusch
Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(7):1236-41.
2011: Martin H Voss; Darren R Feldman; George J Bosl; Robert J Motzer
A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.
Hematology/oncology clinics of North America 2011;25(3):557-76, viii -ix.
2011: Christian Grommes; George J Bosl; Lisa M DeAngelis
Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy.
Cancer 2011;117(9):1911-6.
2011: George J Bosl; Sujata Patil
Carboplatin in clinical stage I seminoma: too much and too little at the same time.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(8):949-52.
2011: Amit Gupta; Andrew H Feifer; Geoffrey T Gotto; Dennis H Kraus; Robert Motzer; George J Bosl; D Bajorin; Darren R Feldman; Brett Carver; Joel Sheinfeld
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.
Urology 2011;77(3):655-9.
2011: R Houston Thompson; Brett S Carver; George J Bosl; Dean F Bajorin; Robert J Motzer; Darren R Feldman; Victor E Reuter; Joel Sheinfeld
Contemporary lymph node counts during primary retroperitoneal lymph node dissection.
Urology 2011;77(2):368-72.
2011: Jean M Torrisi; Lawrence H Schwartz; Marc J Gollub; Michelle S Ginsberg; George J Bosl; Hedvig Hricak
CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity.
Radiology 2011;258(1):41-56.
2010: R Houston Thompson; Brett S Carver; George J Bosl; Dean F Bajorin; Robert J Motzer; Darren R Feldman; Victor E Reuter; Joel Sheinfeld
Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.
Cancer 2010;116(22):5243-50.
2010: Darren R Feldman; Stefan Turkula; Michelle S Ginsberg; Nicole Ishill; Sujata M Patil; Maryann Carousso; George J Bosl; Robert J Motzer
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.
Investigational new drugs 2010;28(4):523-8.
2010: Brett S Carver; Angel M Cronin; Scott E Eggener; Caroline J Savage; Robert J Motzer; Dean F Bajorin; George J Bosl; Joel Sheinfeld
The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
Urology 2010;75(6):1431-5.
2010: Darren R Feldman; Joel Sheinfeld; Dean F Bajorin; Patricia Fischer; Stefan Turkula; Nicole Ishill; Sujata M Patil; Manjit Bains; Lilian M Reich; George J Bosl; Robert J Motzer
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1706-13.
2010: George J Bosl; Robert J Motzer
Weighing risks and benefits of postchemotherapy retroperitoneal lymph node dissection: not so easy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):519-21.
2009: Dana Elizabeth Rathkopf; Mark Dickson; Darren R Feldman; Richard Carvajal; Manish A Shah; Nian Wu; Robert Lefkowitz; Mithat Gonen; Lauren M Cane; Heather J Dials; Jennifer L Winkelmann; George J Bosl; Gary K Schwartz
Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7405-11.
2009: James Korkola; Jane Houldsworth; George J Bosl; Raju S K Chaganti
Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
BJU international 2009;104(9 Pt B):1334-8.
2009: James Korkola; Jane Houldsworth; Darren R Feldman; Adam B Olshen; Li-Xuan Qin; Sujata M Patil; Victor E Reuter; George J Bosl; Raju S K Chaganti
Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5240-7.
2009: George J Bosl
Testicular granulosa cell tumors: rare tumors need to be studied too.
Oncology (Williston Park, N.Y.) 2009;23(9):796.
2009: Anuradha Gopalan; Deepti Dhall; Semra Olgac; Samson W Fine; James Korkola; Jane Houldsworth; Raju S K Chaganti; George J Bosl; Victor E Reuter; SK Tickoo
Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(8):1066-74.
2008: David S Sharp; Brett S Carver; Scott E Eggener; G Varuni Kondagunta; Robert J Motzer; George J Bosl; Joel Sheinfeld
Clinical outcome and predictors of survival in late relapse of germ cell tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5524-9.
2008: Ashwin Jathavedam; Darren R Feldman; Nicole Ishill; Stefan Turkula; Sujata M Patil; George J Bosl; Robert J Motzer; David M Weinstock
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):595-600.
2008: Atreya Dash; Brett S Carver; Jason Stasi; Dean F Bajorin; Robert J Motzer; George J Bosl; Joel Sheinfeld
The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Cancer 2008;112(4):800-5.
2008: Darren R Feldman; George J Bosl; Joel Sheinfeld; Robert J Motzer
Medical treatment of advanced testicular cancer.
JAMA : the journal of the American Medical Association 2008;299(6):672-84.
2008: Darren R Feldman; George J Bosl
Treatment of stage I seminoma: is it time to change your practice?
Journal of hematology & oncology 2008;1():22.
2008: James Korkola; S Heck; Adam B Olshen; Victor E Reuter; George J Bosl; Jane Houldsworth; Raju S K Chaganti
In vivo differentiation and genomic evolution in adult male germ cell tumors.
Genes, chromosomes & cancer 2008;47(1):43-55.
2007: Andrew J Stephenson; George J Bosl; Robert J Motzer; Dean F Bajorin; Jason Stasi; Joel Sheinfeld
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5597-602.
2007: Brett S Carver; Angel M Serio; Dean F Bajorin; Robert J Motzer; Jason Stasi; George J Bosl; Andrew J Vickers; Joel Sheinfeld
Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5603-8.
2007: Brett S Carver; Bobby Shayegan; Scott E Eggener; Jason Stasi; Robert J Motzer; George J Bosl; Joel Sheinfeld
Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4365-9.
2007: Darren R Feldman; G Varuni Kondagunta; Michelle S Ginsberg; Nicole Ishill; Sujata M Patil; John Cestaro; Eugenie A Obbens; Joel Sheinfeld; George J Bosl; Robert J Motzer
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.
Investigational new drugs 2007;25(5):487-90.
2007: Darren R Feldman; George J Bosl
Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials.
Nature clinical practice. Oncology 2007;4(9):508-9.
2007: Bobby Shayegan; Brett S Carver; Jason Stasi; Robert J Motzer; George J Bosl; Joel Sheinfeld
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
BJU international 2007;99(5):993-7.
2007: Brett S Carver; Bobby Shayegan; Angel M Serio; Robert J Motzer; George J Bosl; Joel Sheinfeld
Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1033-7.
2007: Scott E Eggener; Brett S Carver; David S Sharp; Robert J Motzer; George J Bosl; Joel Sheinfeld
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
The Journal of urology 2007;177(3):937-42; discussion 942-3.
2007: Rajendrakumar S V Chadalavada; James Korkola; Jane Houldsworth; Adam B Olshen; George J Bosl; Studer Lorenz; Raju S K Chaganti
Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
Stem cells (Dayton, Ohio) 2007;25(3):771-8.
2007: Scott E Eggener; Brett S Carver; Stacy Loeb; G Varuni Kondagunta; George J Bosl; Joel Sheinfeld
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Cancer 2007;109(3):528-35.
2007: Robert J Motzer; Craig J Nichols; Kim A Margolin; Jennifer Bacik; Paul G Richardson; Nicholas J Vogelzang; Dean F Bajorin; Primo Lara; Lawrence Einhorn; Madhu Mazumdar; George J Bosl
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):247-56.
2007: G Varuni Kondagunta; Jennifer Bacik; Joel Sheinfeld; Dean F Bajorin; Manjit S Bains; Lilian Reich; John Deluca; Amy Budnick; Nicole Ishill; Madhu Mazumdar; George J Bosl; Robert J Motzer
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):85-90.
2006: Jane Houldsworth; James Korkola; George J Bosl; Raju S K Chaganti
Biology and genetics of adult male germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(35):5512-8.
2006: Dean F Bajorin; Robert J Motzer; George J Bosl
Advances in urologic oncology: results progress from successful interdisciplinary research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(35):5479-81.
2006: Brett S Carver; Fernando J Bianco; Bobby Shayegan; Andrew J Vickers; Robert J Motzer; George J Bosl; Joel Sheinfeld
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
The Journal of urology 2006;176(1):100-3; discussion 103-4.
2006: Yungpo Bernard Su; Andrew J Vickers; Michael J Zelefsky; Dennis H Kraus; Ashok R Shaha; Jatin P Shah; Angel M Serio; Louis B Harrison; George J Bosl; David G Pfister
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer.
Cancer journal (Sudbury, Mass.) 2006;12(3):182-8.
2006: James Korkola; Jane Houldsworth; Rajendrakumar S V Chadalavada; Adam B Olshen; Deborah Dobrzynski; Victor E Reuter; George J Bosl; Raju S K Chaganti
Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.
Cancer research 2006;66(2):820-7.
2005: G Varuni Kondagunta; Jennifer Bacik; Dean F Bajorin; Deborah Dobrzynski; Joel Sheinfeld; Robert J Motzer; George J Bosl
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9290-4.
2005: Patrick J Loehrer; George J Bosl
Carboplatin for stage I seminoma and the sword of Damocles.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8566-9.
2005: Ellen A Ronnen; G Varuni Kondagunta; Jennifer Bacik; Stephanie Marion; Dean F Bajorin; Joel Sheinfeld; George J Bosl; Robert J Motzer
Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6999-7004.
2005: G Varuni Kondagunta; Jennifer Bacik; Alessia Donadio; Dean F Bajorin; Stephanie Marion; Joel Sheinfeld; George J Bosl; Robert J Motzer
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6549-55.
2005: Andrew J Stephenson; George J Bosl; Dean F Bajorin; Jason Stasi; Robert J Motzer; Joel Sheinfeld
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
The Journal of urology 2005;174(2):557-60; discussion 560.
2005: James Korkola; Jane Houldsworth; Deborah Dobrzynski; Adam B Olshen; Victor E Reuter; George J Bosl; Raju S K Chaganti
Gene expression-based classification of nonseminomatous male germ cell tumors.
Oncogene 2005;24(32):5101-7.
2005: Andrew J Stephenson; George J Bosl; Robert J Motzer; Michael W Kattan; Jason Stasi; Dean F Bajorin; Joel Sheinfeld
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2781-8.
2005: Rajendrakumar S V Chadalavada; Jane Houldsworth; Adam B Olshen; George J Bosl; Studer Lorenz; Raju S K Chaganti
Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells.
Functional & integrative genomics 2005;5(2):59-69.
2004: Sanjay Koul; James M McKiernan; Gopeshwar Narayan; Jane Houldsworth; Jennifer Bacik; Deborah Dobrzynski; Adel M Assaad; Mahesh Mansukhani; Victor E Reuter; George J Bosl; Raju S K Chaganti; Vundavalli Murty
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.
Molecular cancer 2004;3():16.
2004: G Varuni Kondagunta; Jennifer Bacik; Lawrence H Schwartz; Joel Sheinfeld; Dean F Bajorin; Jacqueline Vuky; Stephanie Marion; Madhu Mazumdar; George J Bosl; Robert J Motzer
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors.
Investigational new drugs 2004;22(2):177-9.
2004: G Varuni Kondagunta; Joel Sheinfeld; Madhu Mazumdar; Tania V Mariani; Dean F Bajorin; Jennifer Bacik; George J Bosl; Robert J Motzer
Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):464-7.
2003: Farhang Rabbani; Hesam Farivar-Mohseni; Antonio Leon; Robert J Motzer; George J Bosl; Joel Sheinfeld
Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma.
Urology 2003;62(6):1092-6.
2003: Alessia Donadio; Robert J Motzer; Dean F Bajorin; Philip W Kantoff; Joel Sheinfeld; Jane Houldsworth; Raju S K Chaganti; George J Bosl
Chemotherapy for teratoma with malignant transformation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4285-91.
2003: James M McKiernan; Robert J Motzer; Dean F Bajorin; Jennifer Bacik; George J Bosl; Joel Sheinfeld
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.
Urology 2003;62(4):732-6.
2003: Joel Sheinfeld; Robert J Motzer; Farhang Rabbani; James M McKiernan; Dean F Bajorin; George J Bosl
Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors.
The Journal of urology 2003;170(4 Pt 1):1159-62.
2003: Kamal S Pohar; Farhang Rabbani; George J Bosl; Robert J Motzer; Dean F Bajorin; Joel Sheinfeld
Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis.
The Journal of urology 2003;170(4 Pt 1):1155-8.
2003: Madhu Mazumdar; Jennifer Bacik; SK Tickoo; Deborah Dobrzynski; Alessia Donadio; Dean F Bajorin; Robert J Motzer; Victor E Reuter; George J Bosl
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2679-88.
2002: Sanjay Koul; Jane Houldsworth; Mahesh Mansukhani; Alessia Donadio; James M McKiernan; Victor E Reuter; George J Bosl; Raju S K Chaganti; Vundavalli Murty
Characteristic promoter hypermethylation signatures in male germ cell tumors.
Molecular cancer 2002;1():8.
2002: Alessia Donadio; George J Bosl
The future of therapy for nonseminomatous germ cell tumors.
Chest surgery clinics of North America 2002;12(4):769-89.
2002: Veronique Bourdon; Felix Naef; Pulivarthi H Rao; Victor E Reuter; Samuel C Mok; George J Bosl; Sanjay Koul; Vundavalli Murty; Raju Kucherlapati; Raju S K Chaganti
Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes.
Cancer research 2002;62(21):6218-23.
2002: Bhuvanesh Singh; Archontoula Stoffel; Swarna Gogineni; Ashok Poluri; David G Pfister; Ashok R Shaha; Alok Pathak; George J Bosl; Carlos Cordon-Cardo; Jatin P Shah; Pulivarthi H Rao
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
The American journal of pathology 2002;161(2):365-71.
2002: Iman Osman; Eric Sherman; Bhuvanesh Singh; Venkatraman E Seshan; Michael J Zelefsky; George J Bosl; Howard I Scher; Jatin P Shah; Ashok R Shaha; Dennis H Kraus; Carlos Cordon-Cardo; David G Pfister
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2980-7.
2002: Jane Houldsworth; Simon C Heath; George J Bosl; Studer Lorenz; Raju S K Chaganti
Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2002;13(6):257-64.
2002: SK Tickoo; Brian Hutchinson; Jennifer Bacik; Madhu Mazumdar; Robert J Motzer; Dean F Bajorin; George J Bosl; Victor E Reuter
Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features.
International journal of surgical pathology 2002;10(1):23-32.
2002: Jacqueline Vuky; SK Tickoo; Joel Sheinfeld; Jennifer Bacik; Alison Amsterdam; Madhu Mazumdar; Victor E Reuter; Dean F Bajorin; George J Bosl; Robert J Motzer
Salvage chemotherapy for patients with advanced pure seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):297-301.
2001: J M Albanese; Victor E Reuter; George J Bosl; Jane Houldsworth; Raju S K Chaganti
Expression of ID genes in differentiated elements of human male germ cell tumors.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2001;10(4):248-54.
2001: T H Dellit; B Armas-Loughran; George J Bosl; Kent A Sepkowitz; Howard T Thaler; J Blaskovich
A method for assessing house staff workload as a function of length of stay.
JAMA : the journal of the American Medical Association 2001;286(9):1023-4.
2001: Madhu Mazumdar; Dean F Bajorin; Jennifer Bacik; G Higgins; Robert J Motzer; George J Bosl
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2534-41.
2001: Farhang Rabbani; Joel Sheinfeld; Hesam Farivar-Mohseni; A Leon; M J Rentzepis; Victor E Reuter; Harry W Herr; John McCaffrey; Robert J Motzer; Dean F Bajorin; George J Bosl
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):2020-5.
2001: Jane Houldsworth; Victor E Reuter; George J Bosl; Raju S K Chaganti
ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines.
Cell and tissue research 2001;303(3):371-9.
2001: Jacqueline Vuky; Manjit S Bains; Jennifer Bacik; G Higgins; Dean F Bajorin; Madhu Mazumdar; George J Bosl; Robert J Motzer
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):682-8.
2000: Jacqueline Vuky; John McCaffrey; Michelle Ginsberg; Tania V Mariani; Dean F Bajorin; George J Bosl; Robert J Motzer
Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors.
Investigational new drugs 2000;18(3):265-7.
2000: Robert J Motzer; Joel Sheinfeld; Madhu Mazumdar; Manjit S Bains; Tania V Mariani; Jennifer Bacik; Dean F Bajorin; George J Bosl
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(12):2413-8.
2000: Robert J Motzer; Madhu Mazumdar; Joel Sheinfeld; Dean F Bajorin; Homer A Macapinlac; Manjit S Bains; Lilian Reich; Carlos D Flombaum; Tania V Mariani; William P Tong; George J Bosl
Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1173-80.
2000: Michael J Morris; George J Bosl
Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
The Journal of urology 2000;163(3):796-801.
1999: Michael J Morris; George J Bosl
High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: the Memorial Sloan-Kettering experience (1988-1999).
International journal of cancer. Journal international du cancer 1999;83(6):834-8.
1999: George J Bosl
Germ cell tumor clinical trials in North America.
Seminars in surgical oncology 1999;17(4):257-62.
1999: Joan Albanell; George J Bosl; Victor E Reuter; M Engelhardt; Sonia Franco; Malcolm A S Moore; Ethan Dmitrovsky
Telomerase activity in germ cell cancers and mature teratomas.
Journal of the National Cancer Institute 1999;91(15):1321-6.
1999: Vundavalli Murty; K Montgomery; S Dutta; S Bala; B Renault; George J Bosl; Raju Kucherlapati; Raju S K Chaganti
A 3-Mb high-resolution BAC/PAC contig of 12q22 encompassing the 830-kb consensus minimal deletion in male germ cell tumors.
Genome research 1999;9(7):662-71.
1999: E J Feuer; Joel Sheinfeld; George J Bosl
Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer.
Journal of the National Cancer Institute 1999;91(10):816-8.
1998: D Liu; A Abolhoda; ME Burt; N Martini; Manjit S Bains; Robert J Downey; Valerie W Rusch; George J Bosl; Robert J Ginsberg
Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience.
The Annals of thoracic surgery 1998;66(5):1709-14.
1998: Pulivarthi H Rao; Jane Houldsworth; Nallasivam Palanisamy; Vundavalli Murty; Victor E Reuter; Robert J Motzer; George J Bosl; Raju S K Chaganti
Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors.
Cancer research 1998;58(19):4260-3.
1998: Louis B Harrison; Adam Raben; David G Pfister; Michael J Zelefsky; EW Strong; Jatin P Shah; Ronald H Spiro; Ashok R Shaha; Dennis H Kraus; Stimson P Schantz; E Carper; B Bodansky; C White; George J Bosl
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck.
Head & neck 1998;20(6):497-503.
1998: W J Maerz; J Baselga; Victor E Reuter; B Mellado; M L Myers; George J Bosl; Michael J Spinella; Ethan Dmitrovsky
FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Oncogene 1998;17(6):761-7.
1998: Jane Houldsworth; H Xiao; Vundavalli Murty; Weiyi Chen; B Ray; Victor E Reuter; George J Bosl; Raju S K Chaganti
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation.
Oncogene 1998;16(18):2345-9.
1998: George J Bosl
Germ cell tumors: there is still plenty to learn.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1244-7.
1998: Pramod C Sogani; Michael Perrotti; Harry W Herr; William R Fair; Howard T Thaler; George J Bosl
Clinical stage I testis cancer: long-term outcome of patients on surveillance.
The Journal of urology 1998;159(3):855-8.
1998: Dean F Bajorin; Madhu Mazumdar; M Meyers; Robert J Motzer; V Vlamis; P Lin; George J Bosl
Metastatic germ cell tumors: modeling for response to chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):707-15.
1998: Robert J Motzer; A Amsterdam; V Prieto; Joel Sheinfeld; Vundavalli Murty; Madhu Mazumdar; George J Bosl; Raju S K Chaganti; Victor E Reuter
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.
The Journal of urology 1998;159(1):133-8.
1997: George J Bosl; K F Malbin
Implementation of practice guidelines.
Oncology (Williston Park, N.Y.) 1997;11(11A):33-8.
1997: John McCaffrey; Dean F Bajorin; Howard I Scher; George J Bosl
Combined-modality therapy for bladder cancer.
Oncology (Williston Park, N.Y.) 1997;11(9 Suppl 9):18-26.
1997: H Y Afifi; George J Bosl; ME Burt
Mediastinal growing teratoma syndrome.
The Annals of thoracic surgery 1997;64(2):359-62.
1997: George J Bosl; Robert J Motzer
Testicular germ-cell cancer.
The New England journal of medicine 1997;337(4):242-53.
1997: John McCaffrey; Madhu Mazumdar; Dean F Bajorin; George J Bosl; V Vlamis; Robert J Motzer
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2559-63.
1997: H Xiao; Madhu Mazumdar; Dean F Bajorin; Michael F Sarosdy; V Vlamis; J Spicer; Jay Ferrara; George J Bosl; Robert J Motzer
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2553-8.
1997: Robert J Motzer; Madhu Mazumdar; Dean F Bajorin; George J Bosl; P Lyn; V Vlamis
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2546-52.
1997: Dean F Bajorin; George J Bosl
Bleomycin in germ cell tumor therapy: not all regimens are created equal.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1717-9.
1997: Harry W Herr; Joel Sheinfeld; H S Puc; Robert T Heelan; Dean F Bajorin; P Mencel; George J Bosl; Robert J Motzer
Surgery for a post-chemotherapy residual mass in seminoma.
The Journal of urology 1997;157(3):860-2.
1997: Jane Houldsworth; Victor E Reuter; George J Bosl; Raju S K Chaganti
Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(3):293-9.
1997: Dean F Bajorin; Robert J Motzer; George J Bosl
Germ cell tumors.
Current therapy in endocrinology and metabolism 1997;6():387-92.
1996: George J Bosl
Development and implementation of clinical management guidelines.
Oncology (Williston Park, N.Y.) 1996;10(11 Suppl):247-53.
1996: Michael J Zelefsky; Dennis H Kraus; David G Pfister; Adam Raben; Jatin P Shah; EW Strong; Ronald H Spiro; George J Bosl; Louis B Harrison
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Head & neck 1996;18(5):405-11.
1996: Vundavalli Murty; B Renault; Catherine T Falk; George J Bosl; R Kucherlapati; Raju S K Chaganti
Physical mapping of a commonly deleted region, the site of a candidate tumor suppressor gene, at 12q22 in human male germ cell tumors.
Genomics 1996;35(3):562-70.
1996: Vundavalli Murty; Victor E Reuter; George J Bosl; Raju S K Chaganti
Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors.
Oncogene 1996;12(12):2719-23.
1996: P C Brenner; Harry W Herr; M J Morse; Joel Sheinfeld; Armen G Aprikian; George J Bosl; Robert J Motzer; Dean F Bajorin; Stimson P Schantz; W R Fair; M Burt
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1765-9.
1996: Robert J Motzer; Madhu Mazumdar; George J Bosl; Dean F Bajorin; A Amsterdam; V Vlamis
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1098-105.
1996: H S Puc; Robert T Heelan; Madhu Mazumdar; Harry W Herr; J Scheinfeld; V Vlamis; Dean F Bajorin; George J Bosl; P Mencel; Robert J Motzer
Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):454-60.
1995: Dennis H Kraus; David G Pfister; Louis B Harrison; Ronald H Spiro; EW Strong; Michael J Zelefsky; George J Bosl; Jatin P Shah
Salvage laryngectomy for unsuccessful larynx preservation therapy.
The Annals of otology, rhinology, and laryngology 1995;104(12):936-41.
1995: Robert J Motzer; Joel Sheinfeld; Madhu Mazumdar; Dean F Bajorin; George J Bosl; Harry W Herr; P Lyn; V Vlamis
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2700-4.
1995: Raju S K Chaganti; George J Bosl
Germ cell tumors: unraveling a biological paradox.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):593-5.
1995: Mark M Moasser; Robert J Motzer; K S Khoo; P Lyn; B A Murphy; George J Bosl; Ethan Dmitrovsky
all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial.
Cancer 1995;76(4):680-6.
1995: Robert J Motzer; T C Chou; Lawrence H Schwartz; George J Bosl; Dean F Bajorin; H Hutter
Paclitaxel in germ cell cancer.
Seminars in oncology 1995;22(3 Suppl 6):12-5.
1995: H S Puc; Dean F Bajorin; George J Bosl; A Amsterdam; Robert J Motzer
Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors.
Investigational new drugs 1995;13(2):163-5.
1995: Dean F Bajorin; Craig Nichols; H J Schmoll; Philip W Kantoff; C Bokemeyer; George D Demetri; L H Einhorn; George J Bosl
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):79-86.
1995: Robert J Motzer; E Rodriguez; Victor E Reuter; George J Bosl; Madhu Mazumdar; Raju S K Chaganti
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):274-82.
1994: S Mathew; Vundavalli Murty; George J Bosl; Raju S K Chaganti
Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
Cancer research 1994;54(23):6265-9.
1994: T M Law; Robert J Motzer; Dean F Bajorin; George J Bosl
The management of patients with advanced germ cell tumors. Seminoma and nonseminoma.
The Urologic clinics of North America 1994;21(4):773-83.
1994: Vundavalli Murty; R G Li; Jane Houldsworth; D L Bronson; Victor E Reuter; George J Bosl; Raju S K Chaganti
Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
Oncogene 1994;9(11):3227-31.
1994: Robert J Motzer; Dean F Bajorin; Lawrence H Schwartz; H S Hutter; George J Bosl; Howard I Scher; P Lyn; P Fischer
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2277-83.
1994: T C Chou; Robert J Motzer; Y Tong; George J Bosl
Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design.
Journal of the National Cancer Institute 1994;86(20):1517-24.
1994: George J Bosl; Dean F Bajorin
Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison.
Seminars in oncology 1994;21(5 Suppl 12):61-4.
1994: Armen G Aprikian; Harry W Herr; Dean F Bajorin; George J Bosl
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Cancer 1994;74(4):1329-34.
1994: Vundavalli Murty; R G Li; S Mathew; Victor E Reuter; D L Bronson; George J Bosl; Raju S K Chaganti
Replication error-type genetic instability at 1q42-43 in human male germ cell tumors.
Cancer research 1994;54(15):3983-5.
1994: Vundavalli Murty; George J Bosl; Jane Houldsworth; M Meyers; A B Mukherjee; Victor E Reuter; Raju S K Chaganti
Allelic loss and somatic differentiation in human male germ cell tumors.
Oncogene 1994;9(8):2245-51.
1994: P K Schultz; Harry W Herr; Zuo-Feng Zhang; Dean F Bajorin; Andrew D Seidman; A Sarkis; W R Fair; D Scherr; George J Bosl; Howard I Scher
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(7):1394-401.
1994: B E Davis; Harry W Herr; W R Fair; George J Bosl
The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy.
The Journal of urology 1994;152(1):111-3; discussion 114.
1994: George J Bosl; Raju S K Chaganti
The use of tumor markers in germ cell malignancies.
Hematology/oncology clinics of North America 1994;8(3):573-87.
1994: Robert J Motzer; E Reed; F Perera; D Tang; H Shamkhani; M C Poirier; W Y Tsai; R J Parker; George J Bosl
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
Cancer 1994;73(11):2843-52.
1994: B A Murphy; Robert J Motzer; Madhu Mazumdar; V Vlamis; J Nisselbaum; Dean F Bajorin; George J Bosl
Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
Cancer 1994;73(10):2520-6.
1994: George J Bosl; David H Ilson; E Rodriguez; Robert J Motzer; Victor E Reuter; Raju S K Chaganti
Clinical relevance of the i(12p) marker chromosome in germ cell tumors.
Journal of the National Cancer Institute 1994;86(5):349-55.
1994: George J Bosl; W R Fair; Harry W Herr; Dean F Bajorin; Guido Dalbagni; Alvaro Sarkis; Victor E Reuter; Carlos Cordon-Cardo; Joel Sheinfeld; Howard I Scher
Bladder cancer: advances in biology and treatment.
Critical reviews in oncology/hematology 1994;16(1):33-70.
1994: Eric J Feuer; C M Frey; Otis W Brawley; S G Nayfield; J B Cunningham; N L Geller; George J Bosl; B S Kramer
After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):368-77.
1994: Louis B Harrison; David G Pfister; Dennis H Kraus; J G Armstrong; Michael J Zelefsky; J Wiseberg; George J Bosl; E W Strong; Jatin P Shah
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation.
Skull base surgery 1994;4(3):127-31.
1994: David G Pfister; Dean F Bajorin; Robert J Motzer; Howard I Scher; C Louison; Louis B Harrison; Jatin P Shah; EW Strong; George J Bosl
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer.
Archives of otolaryngology--head & neck surgery 1994;120(1):89-95.
1994: Dean F Bajorin; Robert J Motzer; George J Bosl
Germ cell tumors.
Current therapy in endocrinology and metabolism 1994;5():354-9.
1994: George J Bosl; M D Head
Serum tumor marker half-life during chemotherapy in patients with germ cell tumors.
The International journal of biological markers 1994;9(1):25-8.
1994: P J Mencel; Robert J Motzer; Madhu Mazumdar; V Vlamis; Dean F Bajorin; George J Bosl
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):120-6.
1993: E Rodriguez; Jane Houldsworth; Victor E Reuter; P Meltzer; J Zhang; Jeffrey M. Trent; George J Bosl; Raju S K Chaganti
Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors.
Genes, chromosomes & cancer 1993;8(4):230-6.
1993: Robert J Motzer; Madhu Mazumdar; S C Gulati; Dean F Bajorin; P Lyn; V Vlamis; George J Bosl
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Journal of the National Cancer Institute 1993;85(22):1828-35.
1993: Robert J Motzer; S C Gulati; William P Tong; C Menendez-Botet; P Lyn; Madhu Mazumdar; V Vlamis; S Lin; George J Bosl
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
Cancer research 1993;53(16):3730-5.
1993: M Parker; Paul Russo; Victor E Reuter; George J Bosl; Deborah Keefe
Intracardiac teratoma 15 years after treatment of a nonseminomatous germ cell tumor.
The Journal of urology 1993;150(2 Pt 1):478-80.
1993: J Armstrong; David G Pfister; EW Strong; R Heimann; Dennis H Kraus; A Polishook; Michael J Zelefsky; George J Bosl; Jatin P Shah; Ronald H Spiro
The management of the clinically positive neck as part of a larynx preservation approach.
International journal of radiation oncology, biology, physics 1993;26(5):759-65.
1993: David H Ilson; Robert J Motzer; E Rodriguez; Raju S K Chaganti; George J Bosl
Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site.
Seminars in oncology 1993;20(3):229-37.
1993: Raju S K Chaganti; E Rodriguez; George J Bosl
Cytogenetics of male germ-cell tumors.
The Urologic clinics of North America 1993;20(1):55-66.
1993: Robert J Motzer; George J Bosl
Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumors.
The Urologic clinics of North America 1993;20(1):111-6.
1993: David G Pfister; Dean F Bajorin; Robert J Motzer; Howard I Scher; C Louison; Louis B Harrison; Jatin P Shah; EW Strong; George J Bosl
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer.
Investigational new drugs 1993;11(1):53-6.
1993: Dean F Bajorin; Robert J Motzer; E Rodriguez; B Murphy; George J Bosl
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Journal of the National Cancer Institute 1993;85(1):60-2.
1993: George J Bosl
Chemotherapy of germ cell tumors: current status and future directions.
European urology 1993;23 Suppl 2():53-6.
1993: George J Bosl
Prognostic factors for metastatic testicular germ cell tumours: the Memorial Sloan-Kettering cancer model.
European urology 1993;23(1):182-7.
1993: Howard I Scher; Dean F Bajorin; Robert J Motzer; George J Bosl
The evolving role of chemotherapy of germ cell tumors.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;126():257-72.
1993: Robert J Motzer; George J Bosl
The current status of salvage chemotherapy for patients with cisplatin-resistant germ cell tumors.
Cancer investigation 1993;11(1):94-6.
1992: Robert J Motzer; Dean F Bajorin; V Vlamis; S Weisen; George J Bosl
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Seminars in oncology 1992;19(6 Suppl 12):8-11.
1992: David P Wood Jr; Harry W Herr; Glenn Heller; V Vlamis; Pramod C Sogani; Robert J Motzer; W R Fair; George J Bosl
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.
The Journal of urology 1992;148(6):1812-5; discussion 1815-6.
1992: Robert J Motzer; George J Bosl
High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions.
Journal of the National Cancer Institute 1992;84(22):1703-9.
1992: G Gastl; CL Finstad; Anna Guarini; George J Bosl; Eli Gilboa; Neil H Bander; B Gansbacher
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
Cancer research 1992;52(22):6229-36.
1992: Vundavalli Murty; Jane Houldsworth; S Baldwin; Victor E Reuter; W Hunziker; Peter Besmer; George J Bosl; Raju S K Chaganti
Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):11006-10.
1992: David P Wood Jr; Harry W Herr; Robert J Motzer; Victor E Reuter; Pramod C Sogani; M J Morse; George J Bosl
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Cancer 1992;70(9):2354-7.
1992: B A Murphy; Robert J Motzer; George J Bosl
Phase II study of iproplatin (CHIP) in patients with cisplatin-refractory germ cell tumors; the need for alternative strategies in the investigation of new agents in GCT.
Investigational new drugs 1992;10(4):327-30.
1992: George J Bosl
The late effects of germ cell tumor chemotherapy: more data are needed.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1375-6.
1992: David H Ilson; Robert J Motzer; R L Kradin; N J Vogelzang; Dean F Bajorin; Howard I Scher; David M Nanus; P O'Moore; K Marathias; George J Bosl
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1124-30.
1992: E Rodriguez; S Mathew; A B Mukherjee; Victor E Reuter; George J Bosl; Raju S K Chaganti
Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization.
Genes, chromosomes & cancer 1992;5(1):21-9.
1992: E Rodriguez; S Mathew; Victor E Reuter; David H Ilson; George J Bosl; Raju S K Chaganti
Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors.
Cancer research 1992;52(8):2285-91.
1992: Robert J Motzer; Dean F Bajorin; George J Bosl
"Poor-risk" germ cell tumors: current progress and future directions.
Seminars in oncology 1992;19(2):206-14.
1992: Dean F Bajorin; Harry W Herr; Robert J Motzer; George J Bosl
Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.
Seminars in oncology 1992;19(2):148-58.
1992: J M Kurie; George J Bosl; Ethan Dmitrovsky
The genetic and biologic aspects of treatment response and resistance in male germ cell cancer.
Seminars in oncology 1992;19(2):197-205.
1992: David G Pfister; Louis B Harrison; E W Strong; George J Bosl
Current status of larynx preservation with multimodality therapy.
Oncology (Williston Park, N.Y.) 1992;6(3):33-8, 43; discussion 44, 47.
1992: Ethan Dmitrovsky; George J Bosl
Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha.
Journal of the National Cancer Institute 1992;84(4):218-9.
1991: Andrew D Seidman; Howard I Scher; M H Heinemann; Dean F Bajorin; C N Sternberg; D David Dershaw; M Silverberg; George J Bosl
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.
Cancer 1991;68(12):2561-5.
1991: David H Ilson; George J Bosl; Robert J Motzer; Ethan Dmitrovsky; Raju S K Chaganti
Genetic analysis of germ cell tumors: current progress and future prospects.
Hematology/oncology clinics of North America 1991;5(6):1271-83.
1991: Louis B Harrison; David G Pfister; D E Fass; J G Armstrong; Roy B Sessions; Jatin P Shah; Ronald H Spiro; EW Strong; S Weisen; George J Bosl
Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer.
International journal of radiation oncology, biology, physics 1991;21(3):703-8.
1991: A B Mukherjee; Vundavalli Murty; E Rodriguez; Victor E Reuter; George J Bosl; Raju S K Chaganti
Detection and analysis of origin of i(12p), a diagnostic marker of human male germ cell tumors, by fluorescence in situ hybridization.
Genes, chromosomes & cancer 1991;3(4):300-7.
1991: G C Toner; N L Geller; S Y Lin; George J Bosl
Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features.
Cancer 1991;67(8):2049-57.
1991: Robert J Motzer; E Rodriguez; Victor E Reuter; F Samaniego; Ethan Dmitrovsky; Dean F Bajorin; David G Pfister; N Z Parsa; Raju S K Chaganti; George J Bosl
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.
Journal of the National Cancer Institute 1991;83(5):341-6.
1991: George J Bosl; N L Geller; Dean F Bajorin
Serum tumor markers and patient allocation to good-risk and poor-risk clinical trials in patients with germ cell tumors.
Cancer 1991;67(5):1299-304.
1991: Robert J Motzer; N L Geller; C C Tan; Harry W Herr; M Morse; W Fair; Joel Sheinfeld; Pramod C Sogani; Paul Russo; George J Bosl
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).
Cancer 1991;67(5):1305-10.
1991: E Rodriguez; Victor E Reuter; C Mies; George J Bosl; Raju S K Chaganti
Abnormalities of 2q: a common genetic link between rhabdomyosarcoma and hepatoblastoma?
Genes, chromosomes & cancer 1991;3(2):122-7.
1991: Louis B Harrison; David G Pfister; George J Bosl
Chemotherapy as part of the initial treatment for nasopharyngeal cancer.
Oncology (Williston Park, N.Y.) 1991;5(2):67-70;discussion 70-1,74,79 passim.
1991: Maurie Markman; R D'Acquisto; N Iannotti; Mark G Kris; T Hakes; Dean F Bajorin; George J Bosl; B Reichman; E Casper; G Magill
Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate.
Journal of cancer research and clinical oncology 1991;117(2):151-5.
1991: George J Bosl; EW Strong; Louis B Harrison; David G Pfister
Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation.
Important advances in oncology 1991;():191-203.
1991: Harry W Herr; G C Toner; N L Geller; George J Bosl
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
European urology 1991;19(1):1-5.
1991: Dean F Bajorin; N L Geller; S F Weisen; George J Bosl
Two-drug therapy in patients with metastatic germ cell tumors.
Cancer 1991;67(1):28-32.
1991: David G Pfister; George J Bosl
BOMM: new solution or old problem?
Cancer investigation 1991;9(5):605-6.
1991: Ethan Dmitrovsky; E Rodriguez; F Samaniego; Victor E Reuter; W H Miller; N L Geller; George J Bosl; Raju S K Chaganti
Analysis of chromosome 12 abnormalities in male germ cell cancers.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1991;123():119-23.
1991: Dean F Bajorin; N L Geller; George J Bosl
Assessment of risk in metastatic testis carcinoma: impact on treatment.
Urologia internationalis 1991;46(3):298-303.
1991: Dean F Bajorin; George J Bosl
Continued refinement in the treatment of germ cell tumour patients.
European journal of cancer (Oxford, England : 1990) 1991;27(6):677-8.
1990: Vundavalli Murty; Ethan Dmitrovsky; George J Bosl; Raju S K Chaganti
Nonrandom chromosome abnormalities in testicular and ovarian germ cell tumor cell lines.
Cancer genetics and cytogenetics 1990;50(1):67-73.
1990: G C Toner; George J Bosl
Sarcoidosis, "Sarcoid-like lymphadenopathy," and testicular germ cell tumors.
The American journal of medicine 1990;89(5):651-6.
1990: Robert J Motzer; Howard I Scher; Dean F Bajorin; C Sternberg; George J Bosl
Phase II trial of Didemnin B in patients with advanced renal cell carcinoma.
Investigational new drugs 1990;8(4):391-2.
1990: G C Toner; N L Geller; C Tan; J Nisselbaum; George J Bosl
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Cancer research 1990;50(18):5904-10.
1990: Robert J Motzer; N L Geller; George J Bosl
The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
Cancer 1990;66(5):857-61.
1990: K Cooper; Dean F Bajorin; W Shapiro; George Krol; Gordon Sze; George J Bosl
Decompression of epidural metastases from germ cell tumors with chemotherapy.
Journal of neuro-oncology 1990;8(3):275-80.
1990: David M Panicek; G C Toner; Robert T Heelan; George J Bosl
Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
Radiology 1990;175(2):499-502.
1990: Ethan Dmitrovsky; Vundavalli Murty; D Moy; W H Miller; D Nanus; A P Albino; F Samaniego; George J Bosl; Raju S K Chaganti
Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
Oncogene 1990;5(4):543-8.
1990: Marc Ladanyi; F Samaniego; Victor E Reuter; Robert J Motzer; Suresh C Jhanwar; George J Bosl; Raju S K Chaganti
Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors.
Journal of the National Cancer Institute 1990;82(3):221-7.
1990: Howard I Scher; Harry W Herr; C Sternberg; W Fair; George J Bosl; M Morse; Pramod C Sogani; R Watson; D Darshaw; Victor E Reuter
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.
Progress in clinical and biological research 1990;353():179-86.
1990: Robert J Motzer; D Niedzwiecki; M Isaacs; C Menendez-Botet; William P Tong; Carlos D Flombaum; Howard I Scher; George J Bosl
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency.
Cancer chemotherapy and pharmacology 1990;27(3):234-8.
1990: G Stoter; George J Bosl; J P Droz; S D Fossa; L S Freedman; N L Geller; A Horwich; W G Jones; S B Kaye; G M Mead
Prognostic factors in metastatic germ cell tumors.
Progress in clinical and biological research 1990;357():313-9.
1990: N I Iannotti; George J Bosl
A review of the management of germ cell tumors: evolution of a curative treatment program.
Cancer investigation 1990;8(2):173-9.
1990: Ethan Dmitrovsky; George J Bosl; Raju S K Chaganti
Clinical and genetic features of human germ cell cancer.
Cancer surveys 1990;9(2):369-86.
1990: S Ganguly; Vundavalli Murty; F Samaniego; Victor E Reuter; George J Bosl; Raju S K Chaganti
Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction.
Genes, chromosomes & cancer 1990;1(3):228-32.
1989: George J Bosl; Ethan Dmitrovsky; Victor E Reuter; F Samaniego; E Rodriguez; N L Geller; Raju S K Chaganti
Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors.
Journal of the National Cancer Institute 1989;81(24):1874-8.
1989: Howard I Scher; Harry W Herr; C Sternberg; W Fair; George J Bosl; M Morse; Pramod C Sogani; R Watson; D David Dershaw; Victor E Reuter
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.
British journal of urology 1989;64(3):250-6.
1989: Raju S K Chaganti; Marc Ladanyi; F Samaniego; Kenneth Offit; Victor E Reuter; Suresh C Jhanwar; George J Bosl
Leukemic differentiation of a mediastinal germ cell tumor.
Genes, chromosomes & cancer 1989;1(1):83-7.
1989: C N Sternberg; A Yagoda; Howard I Scher; George J Bosl; D David Dershaw; K Rosado; C Houston; R Rosenbluth; V Vinciguerra; B Boselli
Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program.
European journal of cancer & clinical oncology 1989;25(4):753-4.
1989: M I Schwarzman; Paul Russo; George J Bosl; W F Whitmore
Hormone-secreting metastatic interstitial cell tumor of the testis.
The Journal of urology 1989;141(3):620-2.
1989: N L Geller; George J Bosl; E Y Chan
Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors.
Cancer 1989;63(3):440-5.
1989: D M Nanus; George J Bosl
Systemic chemotherapy in the management of bladder cancer.
Cancer treatment and research 1989;46():143-58.
1988: Robert J Motzer; Victor E Reuter; Carlos Cordon-Cardo; George J Bosl
Blood group-related antigens in human germ cell tumors.
Cancer research 1988;48(18):5342-7.
1988: George J Bosl; N L Geller; Dean F Bajorin
Identification and management of poor risk patients with germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Seminars in oncology 1988;15(4):339-44.
1988: George J Bosl; N L Geller; Dean F Bajorin; S P Leitner; A Yagoda; R B Golbey; Howard I Scher; N J Vogelzang; J Auman; R Carey
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(8):1231-8.
1988: George J Bosl; N L Geller; E Y Chan
Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors.
Cancer research 1988;48(12):3524-7.
1988: Dean F Bajorin; A Katz; E Chan; N Geller; N Vogelzang; George J Bosl
Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):786-92.
1988: Robert J Motzer; George J Bosl; N L Geller; D Penenberg; A Yagoda; R Golbey; W F Whitmore; W R Fair; Pramod C Sogani; Harry W Herr
Advanced seminoma: the role of chemotherapy and adjunctive surgery.
Annals of internal medicine 1988;108(4):513-8.
1988: Howard I Scher; B Shank; Robert A Chapman; N Geller; C Pinsky; R Gralla; David P Kelsen; George J Bosl; R Golbey; G Petroni
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer.
Cancer research 1988;48(6):1663-70.
1988: Howard I Scher; A Yagoda; Harry W Herr; C N Sternberg; George J Bosl; M J Morse; Pramod C Sogani; R C Watson; D David Dershaw; Victor E Reuter
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.
The Journal of urology 1988;139(3):470-4.
1988: B Vikram; George J Bosl; David G Pfister; W Assad; EW Strong; Ronald H Spiro; Roy B Sessions; F P Gerold; Jatin P Shah
New strategies for avoiding total laryngectomy in patients with head and neck cancer.
NCI monographs : a publication of the National Cancer Institute 1988;(6):361-4.
1988: C N Sternberg; A Yagoda; Howard I Scher; W F Whitmore; Harry W Herr; M J Morse; Pramod C Sogani; George J Bosl; R C Watson; P S Hollander
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
Progress in clinical and biological research 1988;260():551-5.
1988: C N Sternberg; George J Bosl
Advances in testicular cancer--role of chemotherapy.
Progress in clinical and biological research 1988;277():79-84.
1987: Dean F Bajorin; George J Bosl; R Fein
Phase I trial of escalating doses of cisplatin in hypertonic saline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1589-93.
1987: I Haines; George J Bosl; David G Pfister; Ronald H Spiro; F Gerold; Roy B Sessions; Jatin P Shah; EW Strong; B Vikram; Louis B Harrison
Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1594-600.
1987: Robert J Motzer; George J Bosl
Hemorrhage: a complication of metastatic testicular choriocarcinoma.
Urology 1987;30(2):119-22.
1987: S P Leitner; George J Bosl; L M Pelus
Abnormal colony formation and prostaglandin E responsiveness of myeloid progenitor cells in patients cured of germ cell neoplasms after combination chemotherapy.
Cancer 1987;60(3):312-7.
1987: Robert J Motzer; George J Bosl; Robert T Heelan; W Fair; W Whitmore; Pramod C Sogani; Harry W Herr; M Morse
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1064-70.
1987: Harry W Herr; George J Bosl
Residual mass after chemotherapy for seminoma: changing concepts of management.
The Journal of urology 1987;137(6):1234-5.
1987: Robert J Motzer; George J Bosl
Chemotherapy for germ cell tumors.
The Urologic clinics of North America 1987;14(2):389-98.
1987: D A White; L S Schwartzberg; Mark G Kris; George J Bosl
Acute chest pain syndrome during bleomycin infusions.
Cancer 1987;59(9):1582-5.
1987: George J Bosl; N L Geller; N J Vogelzang; R Carey; J Auman; W F Whitmore; Harry W Herr; M Morse; Pramod C Sogani; E Chan
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):436-40.
1987: George J Bosl; Dean F Bajorin; N L Geller
An analysis of poor risk assignment in patients with germ cell tumours.
International journal of andrology 1987;10(1):285-9.
1987: Robert J Motzer; George J Bosl; K Tauer; R Golbey
Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin.
Cancer treatment reports 1987;71(2):197-8.
1987: George J Bosl; Daiva Regina Bajorunas
Pituitary and testicular hormonal function after treatment for germ cell tumours.
International journal of andrology 1987;10(1):381-4.
1987: George J Bosl; S P Leitner; S A Atlas; J E Sealey; J J Preibisz; E Scheiner
Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
International journal of andrology 1987;10(1):353-7.
1987: E S Casper; C A Guidera; George J Bosl; T B Hakes; R J Kaufman; B Shurgot; D W Kinne
Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin.
Breast cancer research and treatment 1987;9(1):39-44.
1986: Dean F Bajorin; George J Bosl; N W Alcock; D Niedzwiecki; E Gallina; B Shurgot
Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline.
Cancer research 1986;46(11):5969-72.
1986: George J Bosl; S P Leitner; S A Atlas; J E Sealey; J J Preibisz; E Scheiner
Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(11):1684-9.
1986: J S Nisselbaum; George J Bosl; Morton K Schwartz
Argument in favor of using mass units to calibrate and report concentrations of human choriogonadotropin.
Clinical chemistry 1986;32(10):1998-2000.
1986: S P Leitner; George J Bosl; Daiva Regina Bajorunas
Gonadal dysfunction in patients treated for metastatic germ-cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(10):1500-5.
1986: George J Bosl; R Gluckman; N L Geller; R B Golbey; W F Whitmore; Harry W Herr; Pramod C Sogani; M Morse; N Martini; Manjit S Bains
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(10):1493-9.
1986: S P Leitner; George J Bosl; EW Strong; F P Gerold; Ronald H Spiro; Jatin P Shah; Roy B Sessions; B Vikram
A pilot study of cisplatin-vinblastine as the initial treatment of advanced head and neck cancer.
Cancer 1986;58(5):1014-7.
1986: P Tiffany; M J Morse; George J Bosl; E D Vaughan; Pramod C Sogani; Harry W Herr; W F Whitmore
Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors.
Cancer 1986;57(5):978-83.
1985: L B Tyson; R J Gralla; R A Clark; Mark G Kris; L A Bordin; George J Bosl
Phase 1 trial of levonantradol in chemotherapy-induced emesis.
American journal of clinical oncology 1985;8(6):528-32.
1985: T Ahmed; George J Bosl; S I Hajdu
Teratoma with malignant transformation in germ cell tumors in men.
Cancer 1985;56(4):860-3.
1985: A Israel; George J Bosl; R B Golbey; W Whitmore; N Martini
The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(8):1073-8.
1985: H Chun; George J Bosl
Phase II trial of mitoguazone in patients with refractory germ cell tumors.
Cancer treatment reports 1985;69(4):461-2.
1985: H Chun; George J Bosl; R B Golbey
Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors.
Cancer treatment reports 1985;69(4):459-60.
1985: George J Bosl; A Yagoda; R B Golbey; W Whitmore; Harry W Herr; Pramod C Sogani; M Morse; N Vogelzang; G MacDonald
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
The American journal of medicine 1985;78(3):423-8.
1985: G F Stanton; George J Bosl; W F Whitmore; Harry W Herr; Pramod C Sogani; M Morse; R B Golbey
VAB-6 as initial treatment of patients with advanced seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(3):336-9.
1985: Mark G Kris; R J Gralla; L B Tyson; R A Clark; David P Kelsen; L K Reilly; S Groshen; George J Bosl; L A Kalman
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
Cancer 1985;55(3):527-34.
1985: J C Allen; George J Bosl; R Walker
Chemotherapy trials in recurrent primary intracranial germ cell tumors.
Journal of neuro-oncology 1985;3(2):147-52.
1985: M J Magee; J Howard; George J Bosl; R E Wittes
Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
Cancer treatment reports 1985;69(1):125-6.
1985: W F Whitmore; George J Bosl
Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center.
Acta urologica Belgica 1985;53(2):341-61.
1984: George J Bosl
Adjuvant surgery in the management of patients with germ cell tumors.
The Annals of thoracic surgery 1984;38(5):432.
1984: S Thongprasert; George J Bosl; N L Geller; R E Wittes
Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Cancer treatment reports 1984;68(10):1301-2.
1984: E J Gold; George J Bosl; L M Itri
Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors.
Cancer treatment reports 1984;68(10):1287-8.
1984: George J Bosl; A Yagoda; W F Whitmore; Pramod C Sogani; Harry W Herr; D Vugrin; M Dukeman; R Golbey
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors.
American journal of clinical oncology 1984;7(4):327-30.
1984: K K Jain; George J Bosl; M S Bains; W F Whitmore; R B Golbey
The treatment of extragonadal seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(7):820-7.
1984: J S Nisselbaum; George J Bosl; R B Golbey; D C Schwartz; Morton K Schwartz
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Annals of clinical and laboratory science 1984;14(3):179-88.
1984: Pramod C Sogani; W F Whitmore; Harry W Herr; George J Bosl; R B Golbey; R C Watson; J J DeCosse
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(4):267-70.
1983: George J Bosl; N L Geller; C Cirrincione; N J Vogelzang; B J Kennedy; W F Whitmore; D Vugrin; Howard I Scher; J Nisselbaum; R B Golbey
Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.
Cancer research 1983;43(7):3403-7.
1983: George J Bosl; N L Geller; C Cirrincione; J Nisselbaum; D Vugrin; W F Whitmore; R B Golbey
Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
The American journal of medicine 1983;75(1):29-35.
1983: Howard I Scher; George J Bosl; N Geller; C Cirrincione; W Whitmore; R Golbey
Impact of symptomatic interval on prognosis of patients with stage III testicular cancer.
Urology 1983;21(6):559-61.
1983: George J Bosl; N Geller; C Cirrincione; S I Hajdu; W Whitmore; J Nisselbaum; D Vugrin; R B Golbey
Interrelationships of histopathology and other clinical variables in patients with germ cell tumors of the testis.
Cancer 1983;51(11):2121-5.
1983: George J Bosl
Adjuvant chemotherapy in the management of stage III and IV tumors of the head and neck.
CA: a cancer journal for clinicians 1983;33(3):139-44.
1982: D Raghavan; N J Vogelzang; George J Bosl; L E Nochomovitz; J Rosai; P H Lange; E E Fraley; A Goldman; J Torkelson; BJ Kennedy
Tumor classification and size in germ-cell testicular cancer: influence on the occurrence of metastases.
Cancer 1982;50(8):1591-5.
1981: George J Bosl; N J Vogelzang; A Goldman; E E Fraley; P H Lange; S H Levitt; B J Kennedy
Impact of delay in diagnosis on clinical stage of testicular cancer.
Lancet 1981;2(8253):970-3.
1981: N J Vogelzang; George J Bosl; K Johnson; B J Kennedy
Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
Annals of internal medicine 1981;95(3):288-92.
1981: George J Bosl; P H Lange; L E Nochomovitz; A Goldmann; E E Fraley; J Rosai; K Johnson; BJ Kennedy
Tumor markers in advanced nonseminomatous testicular cancer.
Cancer 1981;47(3):572-6.
1981: George J Bosl; P H Lange; E E Fraley; A Goldman; L E Nochomovitz; J Rosai; Thomas Waldmann; K Johnson; BJ Kennedy
Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
Cancer 1981;47(2):328-32.
1980: P H Lange; L E Nochomovitz; J Rosai; E E Fraley; BJ Kennedy; George J Bosl; J Brisbane; W J Catalona; J S Cochran; R H Comisarow; K B Cummings; J B deKernion; L H Einhorn; T R Hakala; M Jewett; M R Moore; Peter T Scardino; J M Streitz
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
The Journal of urology 1980;124(4):472-8.
1980: B A Peterson; C D Bloomfield; George J Bosl; G Gibbs; M Malloy
Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia.
Cancer 1980;46(4):663-8.
1980: R K Sibley; J Rosai; E Foucar; L P Dehner; George J Bosl
Neuroendocrine (Merkel cell) carcinoma of the skin. A histologic and ultrastructural study of two cases.
The American journal of surgical pathology 1980;4(3):211-21.
1980: George J Bosl; P H Lange; E E Fraley; L E Nochomovitz; J Rosai; N J Vogelzang; K Johnson; A Goldman; BJ Kennedy
Vinblastine, bleomycin and cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma. Possible importance of longer induction and shorter maintenance schedules.
The American journal of medicine 1980;68(4):492-6.
1980: P H Lange; K Hekmat; George J Bosl; B J Kennedy; E E Fraley
Acclerated growth of testicular cancer after cytoreductive surgery.
Cancer 1980;45(6):1498-506.
1980: G E Ewing; George J Bosl; P K Peterson
Sporothrix schenckii meningitis in a farmer with Hodgkin's disease.
The American journal of medicine 1980;68(3):455-7.
1980: A Goldman; George J Bosl; K Johnson; E E Fraley; B J Kennedy
Prognostic factors in cancer of the testis: an approach to identification.
Cancer treatment reports 1980;64(2-3):487-96.
1980: George J Bosl; R Kwong; P H Lange; E E Fraley; B J Kennedy
Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
Cancer treatment reports 1980;64(2-3):331-4.
1980: George J Bosl; A Yagoda; L H Camara-Lopes
Malignant carcinoid of the gallbladder: third reported case and review of the literature.
Journal of surgical oncology 1980;13(3):215-22.
1979: George J Bosl; J R Edson
Intravascular coagulation.
Minnesota medicine 1979;62(7):544-6.
1979: George J Bosl
Chorionic gonadotrophin and alpha-fetoprotein markers for testicular cancer.
Minnesota medicine 1979;62(7):507-8.